Surgery Partners, which owns or operates 99 surgical facilities across 28 states, raised $271 million by offering 14.3 million shares at $19, well below the range of $23 to $26. Surgery Partners plans to list on the Nasdaq under the symbol SGRY. Surgery Partners initially filed confidentially on 4/22/2015. BofA Merrill Lynch, Goldman Sachs, Jefferies, Citi, Morgan Stanley, Credit Suisse, Raymond James and RBC Capital Markets acted as lead managers on the deal.
The article Surgery Partners prices IPO at $19, well below the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.